Vitamin D Levels Predict All-Cause and Cardiovascular Disease Mortality in Subjects With the Metabolic Syndrome Featured Article: G. Neil Thomas, Ph.D.,

Slides:

Advertisements

Similar presentations

Special Article Adolescent Overweight and Future Adult Coronary Heart Disease Kirsten Bibbins-Domingo, Ph.D., M.D., Pamela Coxson, Ph.D., Mark J. Pletcher,

Advertisements

Investigating Gender Differences in HEDIS Measures Related to Heart Disease Ann F. Chou, PhD, MPH Carol S. Weisman, PhD Rosaly Correa-de-Araujo, MD, PhD.

Michael L. Parchman, MD1 Amer Kassai, PhD2 Jacqueline A. Pugh, MD1

Vitamin D, Health, & CVD Martin P Albert MD

Mortality benefit from reduction in sodium consumption 1 Hypertension affects one-third of the US population, of which less than half have their blood.

Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT): Urinary Screening and Baseline Biochemical and Cardiovascular Assessments Featured.

Genetic Predictors of Weight Loss and Weight Regain After Intensive Lifestyle Modification,Metformin Treatment, or Standard Care in the Diabetes Prevention.

Factors Associated With Weight Gain in People With Type 2 Diabetes Starting on Insulin Featured Article: Beverley Balkau, Philip D. Home, Maya Vincent,

Severe Hypoglycemia and Mortality After Cardiovascular Events for Type 1 Diabetic Patients in Sweden Featured Article: Tom W.C. Lung, Dennis Petrie, William.

The Effect of a Diabetes-Specific Cognitive Behavioral Treatment Program (DIAMOS) for Patients With Diabetes and Subclinical Depression: Results of a Randomized.

Hazard of incident coronary heart disease by diabetes status, with or without elevation of troponin T No diabetes Pre- diabetes Diabetes No diabetes Pre-

Cystatin C– and Creatinine-Based Estimated Glomerular Filtration Rate, Vascular Disease, and Mortality in Persons With Diabetes in the U.S. Featured Article:

Characteristics of 3921 Men Seen by a Primary Care Provider Steven A. Grover, et al, Arch Intern Med. 2005;166:

Consider testing if person is: – Overweight or obese with additional risk factor for diabetes – Age 45 or older Obtain: A1C or FPG or 2-hour plasma glucose.

Impact of Socioeconomic Status on Cardiovascular Disease and Mortality in 24,947 Individuals With Type 1 Diabetes Featured Article: Araz Rawshani, Ann-Marie.

Metabolic Syndrome and Risk of Cancer: A Systematic Review and Meta-Analysis Featured Article: Katherine Esposito, M.D., Ph.D., Paolo Chiodini, Ph.D.,

Treatment and Risk in Heart Failure: Gaps in Evidence or Quality? Pamela N. Peterson, MD MSPH; John S. Rumsfeld, MD PhD; Li Liang PhD; Adrian F. Hernandez,

Early Loss of the Glucagon Response to Hypoglycemia in Adolescents With Type 1 Diabetes Featured Article: Aris Siafarikas, F.R.A.C.P., M.D., Robert J.

Long-Term Complications and Mortality in Young-Onset Diabetes Type 2 diabetes is more hazardous and lethal than type 1 diabetes Featured Article: Maria.

Diabetes and Cause-Specific Mortality in a Prospective Cohort of One Million U.S. Adults Featured Article: Peter T. Campbell, Ph.D., Christina C. Newton,

IRS1 Genotype Modulates Metabolic Syndrome Reversion in Response to 2-Year Weight-Loss Diet Intervention The POUNDS LOST trial Featured Article: Qibin.

Distribution of metabolic syndrome (MS) components by age and gender Zhao D, et al. Am J Cardiol 2007;100:835– 839.

THE DIABETES PREVENTION PROGRAM RESEARCH GROUP*

Haptoglobin 1-1 Genotype is Associated With Poorer Cognitive Functioning in the Elderly With Type 2 Diabetes Featured Article: Ramit Ravona-Springer, M.D.,

Helicobacter pylori Infection Is Associated With an Increased Rate of Diabetes Featured Article: Christie Y. Jeon, Sc.D., Mary N. Haan, Dr.PH., Caroline.

Evaluation of Current Eligibility Criteria for Bariatric Surgery Diabetes prevention and risk factor changes in the Swedish Obese Subjects (SOS) study.

Clinical and Economic Benefits Associated With the Achievement of Both HbA1c and LDL Cholesterol Goals in Veterans With Type 2 Diabetes Featured Article:

Childhood and Adult Secondhand Smoke and Type 2 Diabetes in Women Featured Article: Martin Lajous, M.D., S.C.D., Laura Tondeur, M.S., Guy Fagherazzi, P.H.D.,

Increased Toll-Like Receptor Activity in Patients With Metabolic Syndrome Featured Article: Ishwarlal Jialal, M.D., Ph.D., Beverley A. Huet, Ph.D., Harmeet.

Prognostic Accuracy of Immunologic and Metabolic Markers for Type 1 Diabetes in a High-Risk Population: Receiver Operating Characteristic Analysis Featured.

1 Antonio Bellasi, MD Medical manager Genzyme, Italy Chronic Kidney Disease-Mineral Bone Disorders (CKD-MBD)

Trends in Death Rates Among U.S. Adults With and Without Diabetes Between 1997 and 2006 Featured Article: Edward W. Gregg, Ph.D., Yiling J. Cheng, Ph.D.,

Impact of Physical Activity on Glycemic Control and Prevalence of Cardiovascular Risk Factors in Adults With Type 1 Diabetes: A Cross- sectional Multicenter.

Mortality After Incident Cancer in People With and Without Type 2 Diabetes Featured Article: Craig J. Currie, Ph.D., Chris D. Poole, Ph.D., Sara Jenkins-Jones,

Serum Concentration of Cystatin C and Risk of End-Stage Renal Disease in Diabetes Featured Article: Andrzej S. Krolewski, M.D., Ph.D., James H. Warram,

High Concentrations of AGE-LDL and Oxidized LDL in Circulating Immune Complexes Are Associated With Progression of Retinopathy in Type 1 Diabetes Featured.

Short- and Long-Term Mortality After Myocardial Infarction in Patients With and Without Diabetes Featured Article: Sjoerd T. Nauta, M.S.C., Jaap W. Deckers,

Date of download: 5/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Vitamin D and Cardiovascular Disease: Will It Live.

High Coronary Calcification Scores Predict Mortality in Pre-Dialysis CKD Patients Reference: Haas MH. The risk of death in patients with a high coronary.

The FAVORIT Study (Folic Acid for Vascular Outcome Reduction in Transplantation) Source Bostom AG, Carpenter MA, Kusek JW, et al. Homocysteine-lowering.

Christopher P. Cannon, M. D. , Eugene Braunwald, M. D. , Carolyn H

Individual omega-9 monounsaturated fatty acids and mortality—The Ludwigshafen Risk and Cardiovascular Health Study Graciela E. Delgado, MSc, Bernhard.

Serum Total 25‐OH Vitamin D Adds Little Prognostic Value in Patients Undergoing Coronary Catheterization by Michael E. Gerling, Matthew T. James, Stephen.

The Diabetes Shared Care Program and Risks of Cardiovascular Events in Type 2 Diabetes Edy Kornelius, MD, Jeng-Yuan Chiou, PhD, Yi-Sun Yang, PhD, MD,

Effects of Self-care Health Behaviors on Quality of Life Mediated by Cardiovascular Risk Factors Among Individuals with Coronary Artery Disease: A Structural.

by Peter Ueda, Thomas Wai-Chun Lung, Philip Clarke, and Goodarz Danaei

Muhammad Amer, MD, MHS, FACP, Rehan Qayyum, MD, MHS

by Peter Ueda, Thomas Wai-Chun Lung, Philip Clarke, and Goodarz Danaei

Wesley T. O’Neal et al. JACEP 2016;2:

Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: a mendelian randomisation study Zheng Ye, PhD, Stephen J Sharp, MSc,

Volume 391, Issue 10131, Pages (April 2018)

David J.A. Jenkins et al. JACC 2018;71:

Baseline Characteristics

Subgroup analysis. Subgroup analysis. Effect of vitamin D supplementation on outcome variables in subgroups defined by baseline levels of the respective.

(A) Illustration of the receiver operating characteristic (ROC) curve (discrimination) of the recalibrated model on the external validation set data. (A)

Association of myeloperoxidase with total and cardiovascular mortality in individuals undergoing coronary angiography—The LURIC study Hubert Scharnagl,

Nat. Rev. Cardiol. doi: /nrcardio

The accuracy of the Framingham risk-score in different socioeconomic groups: a prospective study by Peter M Brindle, Alex McConnachie, Mark N Upton, Carole.

David J.A. Jenkins et al. JACC 2018;71:

Incidence rates and HRs for total cardiovascular events and stroke stratified by the TCF7L2-rs polymorphism and the dietary intervention group after.

Adjusted relative risk Adjusted odds ratio

Kaplan-Meier estimation of diabetes-related survival curves in patients grouped according to increased 24-h proteinuria (A), the presence of preexisting.

Baseline predictors for risk of cardiovascular events or all-cause mortality among immigrants with language barriers (N = 87,707). *Adjustment for all.

Multivariate-adjusted HRs (95% CI) for deaths from CV disease (CVD), coronary heart disease (CHD), stroke, and all-cause mortality according to fasting.

Risk differences for incident stroke, coronary heart disease (CHD), and cardiovascular mortality (per 1000 person-years) by clinical risk factor in the.

Kaplan-Meier survival curve for CVD mortality among physically active and inactive type 2 diabetic patients stratified by baseline hs-CRP levels. Kaplan-Meier.

Kaplan-Meier survival analysis for all-cause and CVD mortality in 2,823 type 2 diabetic patients stratified by CKD according to each creatinine-based equation.

Risk for cardiovascular disease and all-cause death according to RHR: (A) as categorical variable (HR≥75 bpm vs HR

Prevalence of nephropathy, retinopathy, and neuropathy in subjects achieving all (A) three targets, (B) two targets, (C) one target, and (D) none, and.

RR (with 95% CI) of total mortality (multivariate-adjusted) by duration of smoking cessation among diabetic women. RR (with 95% CI) of total mortality.

Presentation transcript:

Vitamin D Levels Predict All-Cause and Cardiovascular Disease Mortality in Subjects With the Metabolic Syndrome Featured Article: G. Neil Thomas, Ph.D., Bríain Ó Hartaigh, M.Phil, Jos A. Bosch, Ph.D., Stefan Pilz, M.D., Adrian Loerbroks, Ph.D., Marcus E. Kleber, Ph.D., Joachim E. Fischer, M.D., Tanja B. Grammer, M.D., Bernhard O. Böhm, M.D., Winfried März, M.D. Diabetes Care Volume 35: May, 2012

Study Objectives Optimal vitamin D levels are associated with reduced cardiovascular and all cause mortality Study investigated whether optimal 25-hydroxyvitamin D is protective in individuals with the metabolic syndrome Thomas G et al. Diabetes Care 2012;35:

Study Design 1801 persons with metabolic syndrome in The Ludwigshafen Risk and Cardiovascular Health (LURIC) study of subjects referred for coronary angiography between 1997 and 2000 Mortality tracked for a median of 7.7 years Multivariable survival analysis used to estimate the association between 25(OH)D levels and mortality Thomas G et al. Diabetes Care 2012;35:

Conclusions Optimal 25(OH)D levels substantially lowered all-cause and CVD mortality in subjects with the metabolic syndrome These observations call for interventional studies that test whether vitamin D supplementation provides a useful adjunct in reducing mortality in these subjects Thomas G et al. Diabetes Care 2012;35: